logo-loader
viewCello Health PLC

Cello Health makes strong start to the year; in track to meet expectations

The strategic marketing group has seen revenues, profits and margins advance

1531983915_social-media.jpg
The company provides the full suite of marketing, communications and research services for the healthcare sector

Cello Health plc (LON:CLL) said trading in the first six months of the year had been strong, adding it expects results for the year to be in line with market forecasts.

The healthcare-focused advisory group said it saw “good growth” in revenues and earnings, while profit margins were slightly higher than the comparable period last year.

READ: Cello Health confident of "achieving a successful result in 2018" after strong start to year

The Cello Health division had a “robust” first-half, with "excellent" like-for-like gross profit growth, investors were told.

Cello Signal was described as having had a “solid” start to the year. The company said while gross profit had declined slightly year-on-year, but margins have increased, meaning operating profits will expand slightly.

The businesses acquired last year are now fully absorbed into Cello and “continue to make a good contribution”, the company said.

Quick facts: Cello Health PLC

Price: 129 GBX

AIM:CLL
Market: AIM
Market Cap: £137.53 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cello Group hails the impact of a “vibrant” US on the company’s performance

Chief executive of Cello Group (LON:CLL) Mark Scott spoke to Proactive’s Charlotte Kan in the wake of an upbeat trading update from healthcare and strategic consumer marketing specialist. The research and communications operations both performed well, but there was a common theme to update...

on 05/11/2016

RNS

Holding(s) in Company

3 days, 22 hours ago

Total Voting Rights

4 days, 15 hours ago

Holding(s) in Company

on 10/07/2019

Total Voting Rights

on 10/07/2019

Disposal

on 10/02/2019

Interim Results

on 09/18/2019

Holding(s) in Company

on 08/23/2019

Acquisition of ISS

on 08/16/2019

2 min read